Latest California Healthline Stories
Three-quarters of participants in a newly released study said they did not know of resources for comparing health care costs, while half said that if a website were available to provide such information, they would use it.
Such efforts have previously failed in the face of opposition from the drug industry, which questions their effectiveness and contends prices reflect research and development costs.
Spending on consumer advertising by drugmakers has increased 62 percent since 2012.
Rand Corp. finds that telehealth encourages patients to seek care for minor illnesses they wouldn’t bother to make an office visit for, raising overall health costs.
A new study shows that 83 percent of the largest patient advocacy groups take contributions from drug, medical device or biotech firms.
Drug prices rise for a variety of reasons but opportunities for the government to control them is limited.
Researchers at the University of California, San Francisco estimate that hospitals could lose nearly $1,000 per surgery by throwing away opened but unused supplies, such as gloves and sponges.
The bill would help consumers avoid pricey bills from out-of-network docs.
Liz Helms of the California Chronic Care Coalition takes some surprising positions on prescription drug costs.
A new online “atlas” reveals big differences in the cost and quality of care across California and across health plans.